fluoxetine has been researched along with Abdominal Migraine in 24 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study is the first double-blind placebo-controlled trial of fluoxetine for chronic daily headache (CDH) and migraine." | 9.07 | Double-blind trial of fluoxetine: chronic daily headache and migraine. ( Lake, AE; Saper, JR; Silberstein, SD; Winters, ME, 1994) |
| "This study is the first double-blind placebo-controlled trial of fluoxetine for chronic daily headache (CDH) and migraine." | 5.07 | Double-blind trial of fluoxetine: chronic daily headache and migraine. ( Lake, AE; Saper, JR; Silberstein, SD; Winters, ME, 1994) |
| "Amitriptyline was dosed as follows: 8 mg/day for 6 days, 8 mg twice a day for 6 days, 20 mg/day for 6 days, and 20 mg twice a day for 45 days." | 2.70 | Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. ( Alves, LA; Barbosa, JS; Krymchantowski, AV; Silva, MT, 2002) |
| "Sixty-five patients needing migraine prophylaxis were recruited into a phase II, double-blind, placebo-controlled trial." | 2.69 | S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study. ( Ahmed, F; Findley, LJ; MacGregor, EA; Steiner, TJ; Wilkinson, M, 1998) |
| "The duration of the therapy of migraine between the attacks was 12 weeks." | 2.69 | [A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period]. ( Amelin, AV; Gonchar, MA; Korenko, LA; Skoromets, AA; Tumelevich, BCh, 2000) |
| "Fluoxetine appears to be a safe and effective drug for migraine prophylaxis, and deserves further therapeutic trials with larger groups for longer periods of time." | 2.67 | Fluoxetine prophylaxis of migraine. ( Adly, C; Chesson, A; Straumanis, J, 1992) |
| "Migraine is affected by fluctuating estrogen levels so it is not surprising that the perimenopause is a time of peak rate of change of migraine prevalence in women." | 2.48 | Perimenopausal migraine in women with vasomotor symptoms. ( MacGregor, EA, 2012) |
| "The association of migraine and depression has been confirmed in numerous studies and it has been suggested that both diseases influence each other in a bidirectional way." | 2.44 | [A clinical challenge. Pragmatic treatment of migraine and concomitant depression]. ( Jürgens, TP; Koch, HJ; Leinisch, E, 2008) |
| "Major depression and migraine are commonly comorbid." | 1.30 | Co-administration of fluoxetine and sumatriptan: the Canadian experience. ( Joffe, RT; Sokolov, ST, 1997) |
| "Serotonin syndrome is the result of the drug interaction that enhances serotonergic tone in the central nervous system." | 1.30 | Serotonin syndrome presenting with migrainelike stroke. ( Molaie, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (54.17) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, AH | 1 |
| Kearney, T | 1 |
| Jabre, MG | 1 |
| Shahidi, GA | 1 |
| Bejjani, BP | 1 |
| MacGregor, EA | 2 |
| Krymchantowski, AV | 1 |
| Silva, MT | 1 |
| Barbosa, JS | 1 |
| Alves, LA | 1 |
| Akarachkova, ES | 1 |
| Tabeeva, GR | 1 |
| Volkova, ZI | 1 |
| Dlusskaia, IG | 1 |
| Striuk, RI | 1 |
| Veĭn, AM | 1 |
| Ignatov, IuD | 1 |
| Skoromets, AA | 2 |
| Amelin, AV | 2 |
| Finfgeld, DL | 1 |
| Bonetto, N | 1 |
| Santelli, L | 1 |
| Battistin, L | 1 |
| Cagnin, A | 1 |
| Jürgens, TP | 1 |
| Leinisch, E | 1 |
| Koch, HJ | 1 |
| Evans, RW | 1 |
| Saper, JR | 2 |
| Silberstein, SD | 2 |
| Lake, AE | 2 |
| Winters, ME | 2 |
| Szabo, CP | 1 |
| Larson, EW | 1 |
| Petkov, VD | 1 |
| Belcheva, S | 1 |
| Konstantinova, E | 1 |
| Joffe, RT | 1 |
| Sokolov, ST | 1 |
| Molaie, M | 1 |
| Steiner, TJ | 1 |
| Ahmed, F | 1 |
| Findley, LJ | 1 |
| Wilkinson, M | 1 |
| Boon, F | 1 |
| Oguzhanoglu, A | 1 |
| Sahiner, T | 1 |
| Kurt, T | 1 |
| Akalin, O | 1 |
| Korenko, LA | 1 |
| Tumelevich, BCh | 1 |
| Gonchar, MA | 1 |
| Petitto, JM | 1 |
| Mundle, LB | 1 |
| Nagy, BR | 1 |
| Evans, DL | 1 |
| Golden, RN | 1 |
| Adly, C | 1 |
| Straumanis, J | 1 |
| Chesson, A | 1 |
4 reviews available for fluoxetine and Abdominal Migraine
| Article | Year |
|---|---|
Perimenopausal migraine in women with vasomotor symptoms.
Topics: Amines; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Estrogens; Female; Fluoxetine; Ga | 2012 |
[Current views on migraine and anti-migraine preparations].
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Analgesics, No | 2003 |
Serotonin syndrome and the use of SSRIs.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Therapy, Combination; Fem | 2004 |
[A clinical challenge. Pragmatic treatment of migraine and concomitant depression].
Topics: Amitriptyline; Analgesics, Non-Narcotic; Antidepressive Agents, Second-Generation; Antidepressive Ag | 2008 |
7 trials available for fluoxetine and Abdominal Migraine
| Article | Year |
|---|---|
Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Constipation; Double-Blind Method; Drug Therapy, | 2002 |
Fluoxetine and migraine: comparison of double-blind trials.
Topics: Chronic Disease; Double-Blind Method; Fluoxetine; Headache; Humans; Migraine Disorders; Multivariate | 1995 |
Double-blind trial of fluoxetine: chronic daily headache and migraine.
Topics: Adult; Affect; Chronic Disease; Double-Blind Method; Female; Fluoxetine; Headache; Humans; Male; Mid | 1994 |
S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study.
Topics: Adult; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Migraine Disorders; Selec | 1998 |
Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches.
Topics: Adult; Amitriptyline; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Administration S | 1999 |
[A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period].
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Analgesics, Non-Narcotic; Female; | 2000 |
Fluoxetine prophylaxis of migraine.
Topics: Double-Blind Method; Female; Fluoxetine; Humans; Male; Migraine Disorders; Pilot Projects | 1992 |
13 other studies available for fluoxetine and Abdominal Migraine
| Article | Year |
|---|---|
Lack of impairment due to confirmed codeine use prior to a motor vehicle accident: role of pharmacogenomics.
Topics: Accidents, Traffic; Analgesics, Opioid; Bupropion; Codeine; Cytochrome P-450 CYP2D6; Dopamine Uptake | 2013 |
Probable fluoxetine-induced carotidynia.
Topics: Adult; Carotid Artery Diseases; Fluoxetine; Humans; Male; Migraine Disorders; Neck Pain; Selective S | 2009 |
[Clinical significance of adrenoreactivity in patients with some paroxysmal disorders (panic attacks and migraine)].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Citalopram; Diagnostic and Statistical Manual of Men | 2003 |
Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum.
Topics: Adult; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypericum; Migraine Disorders; Rhabdom | 2007 |
Triptans and serotonin syndrome.
Topics: Adult; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypericum; Migraine Disorders; Rhabdom | 2008 |
Fluoxetine and sumatriptan: possibly a counterproductive combination.
Topics: Acute Disease; Adult; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Flu | 1995 |
Migraine with typical aura associated with fluoxetine therapy: case report.
Topics: Agoraphobia; Fluoxetine; Functional Laterality; Humans; Male; Middle Aged; Migraine Disorders; Panic | 1993 |
Anxiolytic effects of dotarizine, a possible antimigraine drug.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzhydryl Compounds; Exploratory Behavior; Fluoxetine; Male; | 1995 |
Co-administration of fluoxetine and sumatriptan: the Canadian experience.
Topics: Canada; Depression; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Migraine Disor | 1997 |
Serotonin syndrome presenting with migrainelike stroke.
Topics: Adult; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Clomipramine; Confusi | 1997 |
Cyproheptadine and SSRIs.
Topics: Adolescent; Cyproheptadine; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Fe | 1999 |
S-fluoxetine.
Topics: Clinical Trials, Phase II as Topic; Fluoxetine; Humans; Migraine Disorders; Placebos; Selective Sero | 1999 |
Improvement of arthritis with fluoxetine.
Topics: Arthritis; Female; Fluoxetine; Humans; Middle Aged; Migraine Disorders; Pain; Selective Serotonin Re | 1992 |